Search Results

You are looking at 71 - 80 of 560 items for :

  • development x
  • All content x
Clear All
Open access

Nafiye Helvaci, Erdem Karabulut, Ahmet Ugur Demir, and Bulent Okan Yildiz

dysfunction, decreased quality of life and increased risk of accidents. There is also strong evidence suggesting that OSA contributes to the development of hypertension, cardiovascular disease and abnormalities in glucose metabolism ( 6 , 7 , 8 ). According

Open access

Shenglong Le, Leiting Xu, Moritz Schumann, Na Wu, Timo Törmäkangas, Markku Alén, Sulin Cheng, and Petri Wiklund

Introduction Sex steroids are important regulators of pubertal development and their biological action is governed by sex hormone-binding globulin (SHBG) ( 1 ). Serum SHBG levels rise from birth to early childhood, then decline in early

Open access

Fiona Broughton Pipkin, Hiten D Mistry, Chandrima Roy, Bernhard Dick, Jason Waugh, Rebecca Chikhi, Lesia O Kurlak, and Markus G Mohaupt

Introduction The fetal adrenal gland and hypothalamic–pituitary axis (HPA) play important roles during pregnancy. Between weeks 32 and 34 of gestation, there is a rapid maturation of the fetal adrenal cortex, allowing development of a variety of

Open access

Katherine Van Loon, Li Zhang, Jennifer Keiser, Cendy Carrasco, Katherine Glass, Maria-Teresa Ramirez, Sarah Bobiak, Eric K Nakakura, Alan P Venook, Manisha H Shah, and Emily K Bergsland

symptoms, and the development of any SRE were abstracted. Bone metastases were considered synchronous if they were identified within 3 months of diagnosis of the primary tumor. If bone metastases were identified beyond 3 months after diagnosis, they were

Open access

Elizabeth Yan Zhang and Bao-Ting Zhu

estrogens, such as those observed during human pregnancy, are immunosuppressive (1) . For example, 17β-estradiol (E 2 ) and estriol (E 3 ) at suitable doses can inhibit the development of experimental autoimmune encephalomyelitis (EAE) (2, 3, 4) and

Open access

Urszula Smyczyńska, Joanna Smyczyńska, Maciej Hilczer, Renata Stawerska, Ryszard Tadeusiewicz, and Andrzej Lewiński

defined by Ranke as a new paradigm for GH treatment in 21st century ( 3 ). Moreover, the use of growth prediction models has been proposed as a personalized approach to GH treatment in clinical practice ( 4 ). Development of such models should allow to

Open access

Ailsa Maria Main, Maria Rossing, Line Borgwardt, Birgitte Grønkær Toft, Åse Krogh Rasmussen, and Ulla Feldt-Rasmussen

first screening. The family members with PPGLs displayed markers of poor prognosis including metastatic disease and markers included in the PASS (Supplementary material) and the variant might be associated with a high risk of tumour development in adults

Open access

Leanne Hodson and Fredrik Karpe

tissue) and how dysregulation of these processes may play a role in the development of insulin resistance and/or IHTAG accumulation in humans. Although there are new therapies in the pipeline for the treatment of NAFLD/insulin resistance, there are many

Open access

Corina Verónica Sasso, Flavia Eliana Santiano, Fiorella Campo Verde Arboccó, Leila Ester Zyla, Silvana Noemí Semino, Martin Eduardo Guerrero-Gimenez, Virginia Pistone Creydt, Constanza Matilde López Fontana, and Rubén Walter Carón

40%, respectively, higher in men than in women ( 1 ). Since the Women’s Health Initiative in 1991 ( 2 ), and several epidemiological studies, the ovarian steroids were considered protectors against the development of CRC. Different studies in animal

Open access

T L C Wolters, C D C C van der Heijden, N van Leeuwen, B T P Hijmans-Kersten, M G Netea, J W A Smit, D H J Thijssen, A R M M Hermus, N P Riksen, and R T Netea-Maier

, which promotes a pro-inflammatory and pro-atherogenic environment. Although the importance of innate immune cells in the development and progression of atherosclerosis is widely accepted, the unresolving character of the low-grade inflammation that